We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Endo announced the appointment of Domenic Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics, effective immediately.
Sangamo Therapeutics announced the appointment of Gary H. Loeb as Executive Vice President and General Counsel, effective immediately. Loeb will oversee all legal matters for Sangamo and will report to the Chief Executive Officer.